Chester County News and Community Website
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) announced that it recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for IMM-BCP-01, a three-antibody …
Immunome Announces Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19 Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the U.S. Food and Drug Administration (FDA) has issued a clinical hold on the Company’s Investigational New Drug application (IND) to …
FDA Places Hold on Ocugen’s Investigational New Drug Application Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being performed under a Cooperative Research and Development Agreement (CRADA) …
Virpax to Use Envelta IND Enabling Study Results for Two Additional Indications Read More
WASHINGTON, D.C. — The following quote is attributed to Janet Woodcock, M.D., Acting FDA Commissioner:
FDA Provides Guidance on Master Protocols for Evaluating Prevention, Treatment Options for COVID-19 Read More